Mackenzie Financial Corp Cytokinetics Inc Transaction History

Mackenzie Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	BUY	$26.88 - $83.49 $162,865 - $505,865	6,059 New	6,059 $505,000
Q2 2023 Aug 03, 2023	BUY	$32.62 - $40.75 $197,644 - $246,904	6,059 New	6,059 $197,000
Q4 2022 Feb 14, 2023	SELL	$35.77 - $51.11 $9,693 - $13,850	-271 Reduced 5.01%	5,139 $235,000
Q3 2022 Oct 07, 2022	SELL	$38.54 - $54.52 $2.09 Million - $2.95 Million	-54,171 Reduced 90.92%	5,410 $262,000
Q2 2022 Aug 10, 2022	BUY	$33.93 - $48.92 $2.02 Million - $2.91 Million	59,581 New	59,581 $2.34 Million

409

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.6B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.